Dissection of yeast pleiotropic drug resistance regulation reveals links between cell cycle regulation and control of drug pump expression
Authors:
- Robert P. St.OngeRSRobert P. St.Onge
- Maureen E. HillenmeyerMHMaureen E. Hillenmeyer
- Colin J.B. HarveyCHColin J.B. Harvey
Preprint
Abstract
Summary: Eukaryotes utilize a highly-conserved set of drug efflux transporters to confer pleiotropic drug resistance (PDR). Despite decades of effort interrogating this process, multiple aspects of the PDR process, in particular PDR regulation, remain mysterious. In order to interrogate the regulation of this critical process, we have developed a small-molecule responsive biosensor that couples PDR transcriptional induction to growth rate in Saccharomyces cerevisiae . We applied this system to genome-wide screens for potential PDR regulators using the homozygous diploid deletion collection. These screens identified and characterized a series of genes with significant but previously uncharacterized roles in the modulation of the yeast PDR in addition to recapitulating previously-known factors involved in PDR regulation. Furthermore, we demonstrate that disruptions of the mitotic spindle checkpoint assembly lead to elevated PDR response in response to exposure to certain compounds. These results not only establish our biosensor system as a viable tool to investigate PDR in high-throughput, but also uncovers novel control mechanisms governing PDR response and a previously uncharacterized link between this process and cell cycle regulation. Significance: Pleiotropic drug resistance (PDR) is a conserved mechanism by which cells utilize membrane bound pumps to transport chemicals out of the cell. Here, we develop a growth-based biosensor system in yeast that enables high-throughput identification of factors that transcriptionally regulate PDR. Among the novel PDR regulators identified here, we show that spindle assembly checkpoint (SAC) proteins, which are important for cell cycle regulation, inhibit hyperactivation of PDR upon drug treatment. This result provides insights into PDR regulation, as well as potential targets for therapeutic intervention, particularly in chemoresistant cancers where the cell cycle regulation is often disrupted.Keywords
All Related Versions
- Published version: Journal of Biological Chemistry, 294 (4), 1257.
This publication has 39 references indexed in Scilit:
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- Mitosis-targeted anti-cancer therapies: where they standCell Death & Disease, 2012
- Multiplex assay for condition-dependent changes in protein–protein interactionsProceedings of the National Academy of Sciences, 2012
- Saccharomyces Genome Database: the genomics resource of budding yeastNucleic Acids Research, 2011
- The Chromatin Signaling Pathway: Diverse Mechanisms of Recruitment of Histone-Modifying Enzymes and Varied Biological OutcomesMolecular Cell, 2010
- Multidrug Resistance in BacteriaAnnual Review of Biochemistry, 2009
- Evidence for the Bifunctional Nature of Mitochondrial Phosphatidylserine Decarboxylase: Role in Pdr3-Dependent Retrograde Regulation of PDR5 ExpressionMolecular and Cellular Biology, 2008
- Multidrug Resistance in FungiEukaryotic Cell, 2007
- Spindle checkpoint function and cellular sensitivity to antimitotic drugsMolecular Cancer Therapeutics, 2006
- Functional profiling of the Saccharomyces cerevisiae genomeNature, 2002